The Standard Life share price is up 34% in 6 months. Should I buy now?

The FTSE 100 asset manager is facing increased costs and competition, but provides one of the highest dividend yields in the index.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

UK stocks have taken a hit over the last year with the impact of the pandemic, but many have recovered recently as part of a stock market rally. Whether this rally can be sustained or is part of a bubble is up for debate, but I still see opportunities in the market at the moment.

During turbulent times, I tend to look towards companies with a long and stable history of weathering difficult economic conditions. There are few in the FTSE 100 that have been around as long as Standard Life Aberdeen (LSE:SLA).

The Standard Life share price is now 34% higher than it was six months ago. While the shares have only gained 1% in 12 months, given the overall state of the Footsie during that time the shares’ performance is better than average.

So would I buy Standard Life shares today for my portfolio?

Strong and stable

Standard Life has been around a long time. The company was first founded in 1825 and provides asset management, insurance, and savings services to both individuals and corporate bodies.

Historically speaking, the company has not provided great long-term returns for investors. The share price has returned a loss over the last five years despite its recent rally. Investors don’t seem to have been convinced by the 2017 merger between Standard Life and Aberdeen Asset Management.

Costs and competition have both been rising over the last number of years, which haven’t exactly helped the company’s bottom line. Profits for the company’s first half last year were 30% lower than the year before.

So what has been driving the Standard Life share price higher in recent months?

Broker action

One reason could be that analysts at both JP Morgan and Berenberg upgraded their broker recommendations for the company. JP Morgan said there were several opportunities to close the ‘value gap’ between Standard Life and its competitors, including a reduction in dividends. The company currently has one of the highest dividend yields in the FTSE 100 at roughly 7%.

Berenberg analysts also recommended a dividend cut so the company can focus on earnings growth, while upgrading the stock to ‘buy’ from ‘hold’.

Important decisions will need to be made by new CEO Stephen Bird. Standard Life clearly needs to focus more on growth, but cutting the dividend could put off potential investors as well. How the new management deals with that dilemma will have an impact on the share price going forward.

There is the potential for mergers and acquisitions to fuel growth, and management has indicated that it will consider this option.

That said, I will need more convincing of the company’s ability to drive the share price higher in the long term. A key metric for Standard Life is assets under management, which has been falling for some time. Its most recent earnings report had their assets under management at £511bn.

Until this heads in the right direction I won’t be buying the Standard Life share price for my portfolio.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

conorcoyle has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »